$BNB A Windtree Therapeutics, a company focused on the treatment of cardiovascular diseases in the United States, will create a BNB reserve. To this end, the company announced on Thursday (24) that it raised $520 million in new funding rounds.

According to the announcement, the goal of the round is to accelerate its strategy of maintaining BNB as a reserve asset. And with the funds raised, Windtree aims to be the global leader in reserves of the Binance token.